OVERVIEW
From 2020-2025, the global market for ophthalmology drugs and devices is expected to rise at a CAGR of 5.11%. Owing to the growing incidence and prevalence of eye-related disorders such as presbyopia, macular degeneration and diabetic retinopathy among the aging population, the global demand for ophthalmology devices and drugs is experiencing a substantial increase.
TABLE OF CONTENT
1 Global Ophthalmology Drugs & Devices Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Ophthalmology Drugs & Devices Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Ophthalmology Drugs & Devices Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Ophthalmology Drugs & Devices Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Ophthalmology Drugs & Devices Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Ophthalmology Drugs & Devices Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Ophthalmology Drugs & Devices Market – By Surgery (Market Size – & million/billion)
8.1 Cataract Surgery Devices
8.2 Glaucoma Surgery Devices
8.3 Refractive Surgery Devices
8.4 Excimer Laser
8.5 Microkeratome
8.6 Femtosecond Laser
8.7 YAG Laser
8.8 Others
9 Global Ophthalmology Drugs & Devices Market – By Equipment
9.1 Optical Coherence Tomographers (OCT Scanners)
9.2 Fundus cameras
9.3 Ophthalmic Ultrasound Imaging Systems
9.4 Ophthalmoscopes
9.5 Slit lamps
9.6 Visual Field Analyzers/Perimeters
9.7 Wavefront aberrometers
9.8 Tonometers
9.9 Others
10 Global Ophthalmology Drugs & Devices Market – By Geography (Market Size – &
million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa
11 Global Ophthalmology Drugs & Devices Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships
12 Global Ophthalmology Drugs & Devices Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Abbott Medical Optics, Inc.
12.3 Alcon Inc.
12.4 Insight Vision Inc.
12.5 Allergan, Inc.
12.6 Bausch & Lomb Inc.
12.7 Ellex Medical Lasers Ltd.
12.8 Essilor International S.A.
12.9 Iridex
12.10 Johnson & Johnson Vision Care, Inc.
12.11 Carl-Zeiss AG
12.12 Hoya Corporation
12.13 Company 11 & more
13 Global Ophthalmology Drugs & Devices Market – Appendix
13.1 Sources
13.2 Abbreviations